I spoke to Pierre van Weperen who is Managing Director at Grow Biotech UK and Chair of the Board at Dutch National MS Society.
Grow Biotech are working with manufacturers to make a broad range of medicinal cannabis products available in the UK and their R&D team creates and patents new technologies for Medicinal Cannabis producers to create better, cost-effective medicines.
Pierre talked passionately about unlocking the potential of medicinal cannabis, making it available for those who need it in an affordable way.
This has been a hot topic in the industry for years. I previously spoke about it in my article "Why Cannabis Is a Risk Worth Taking for Big Pharma". You can find more of my content that covers the pharmaceutical and specialty chemicals markets here.
If you’d like to get involved in the conversation, send us an email to cmconversations@charltonmorris.com
Alongside the growing trend of value-based searches, I wanted to delve into why candidates prioritise companies that focus on fundamental principles and ethics which resonate with them, as opposed to other more material benefits. Find out why, here.
In this episode, Jack speaks with two Co-Founders at Centivax about life as successful entrepreneurs, the journey to acquisition, challenges and learnings - and using them to become an industry-defining author. Listen now.
AI is revolutionising the world of CRO development and clinical trials - but what are the main benefits of adopting the tech? In this article we explore them, with the help of experts working in the space.
Comments.